- JP-listed companies
- Modalis Therapeutics Corporation
- Income statement
Modalis Therapeutics Corporation【JP:4883】Income statement
Market cap
¥4.3B
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | - | 18 | 65 | 645 | 342 | 1 | 41 | - | - | - |
| Revenue growth (%) | - | - | - | - | - | |||||
| Operating margin (%) | - | - | - | - | - | - | ||||
| Operating expenses | - | - | - | 184 | 208 | 231 | 242 | 268 | 245 | 232 |
| Operating income | - | - | - | 157 | -398 | -1,239 | -2,063 | -2,371 | -1,338 | -2,211 |
| Income before tax | -46 | -141 | -213 | 146 | -440 | -1,231 | -1,996 | -2,352 | -1,303 | -2,148 |
| Pretax margin (%) | - | -787.9 | -326.8 | 22.7 | -128.5 | -111,936.3 | -4,927.9 | - | - | - |
| Provision for income taxes | - | - | - | 6 | 9 | -6 | -4 | 1 | 1 | 2 |
| Effective tax rate (%) | - | - | - | |||||||
| Net income | -46 | -142 | -230 | 141 | -448 | -739 | -2,703 | -2,392 | -1,318 | -2,153 |
| Net income margin (%) | - | - | - | - | ||||||
| Earnings per share | -366.78 | -1,028.95 | -10.84 | 5.96 | -17.02 | -25.7 | -92.85 | -77.24 | -28.57 | -27.86 |
| Dividend per share | - | - | - | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | |||||
| EBITDA margin (%) | - | - | - | - | - | - |